Robot reaches milestone, passes medical licensing exam

An artificial intelligence-powered robot in China took the country’s medical licensing examinations and passed, becoming the first robot to do so, Futurism reports.

Advertisement

The robot, Xiaoyi, not only passed the tests, but it did so with flying colors — 96 points above the required marks. Developed by leading Chinese AI company iFlytek Co., it was designed to capture and analyze patient information, but its skills go beyond that, demonstrating the medical knowledge necessary to be a licensed practitioner, according to Futurism.

The company plans to use Xiaoyi to aid human physicians and improve their efficiency in treating patients.

“We will officially launch the robot in March 2018. It is not meant to replace doctors. Instead, it is to promote better people-machine cooperation so as to boost efficiency,” iFlytek Chairman Liu Qingfeng told China Daily. “General practitioners are in severe shortage in China’s rural areas. We hope AI can help more people access quality medical [resources].”

More articles on artificial intelligence:

Germany-based Ada Health gains $47M; will use funds to open US office

Boston researchers use AI chatbot to guide patients through end-of-life care

WSJ: AI drives competition among chip makers

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.